Millrock Technology (Millrock) is a leading designer and manufacturer of high-performance lyophilization (freeze-drying) equipment and technologies that enable critical advances in life sciences, pharmaceuticals, and biotechnology. Millrock’s precision-engineered systems support essential applications in diagnostics, personalized medicine, vaccine development, biologics, and therapeutic manufacturing—areas where product integrity, reliability, and efficiency directly impact human health outcomes.
Since its founding, Millrock has built a reputation as one of the most innovative and customer-focused providers of freeze-drying solutions in the world. The company offers a comprehensive suite of laboratory, pilot, and production-scale lyophilizers, as well as advanced process control instrumentation that improves product quality, enhances cycle efficiency, and accelerates time-to-market.
Millrock’s deep expertise in thermal sciences, engineering, and process development has established it as a trusted partner to blue-chip pharmaceutical companies, biotech innovators, and government research agencies. Its technologies are deployed globally to advance vaccine stability, enable next-generation biologics, and support cutting-edge cell and gene therapies.
Millrock exemplifies the kind of highly engineered, mission-critical technology company that Artemis seeks to partner with. Their differentiated capabilities in freeze-drying technology, combined with an unwavering focus on advancing human health, align directly with our investment thesis. Together, we are excited to scale Millrock into the industry’s most trusted partner for enabling life-saving therapies.
With Artemis’ support, Millrock is positioned to accelerate its growth as a premier provider of advanced lyophilization solutions to the global life sciences and pharmaceutical industries. The vision is to expand Millrock’s reach as the most innovative and reliable partner for customers developing therapies that safeguard and extend human health.
Stay tuned for updates as the Artemis–Millrock partnership delivers on this vision—advancing critical medicines, diagnostics, and treatments that improve lives worldwide.
Wakefield, MA, 29 September, 2026 - Optikos®, a provider of engineering, manufacturing, and metrology services in optical systems, has acquired Omega Optical, […]
Boston, MA – September 15, 2026 – Artemis Capital Partners (“Artemis” or the “Firm”), a Boston-based private equity firm focused exclusively on […]
BEAVER FALLS, PA - May 2026 - McDanel Advanced Material Technologies (“McDanel” or the “Company”), a manufacturer of advanced material solutions for […]